AbbVie Inc (NYSE:ABBV)

55.69 BATS BZX Real-Time Price As of 1:22pm ET	-1.17 / -2.06% Today’s Change	45.50 Today\|\|\|52-Week Range 70.76	-14.90% Year-to-Date

55.69

BATS BZX Real-Time Price

As of 1:22pm ET

-1.17 / -2.06%

Today’s Change

45.50

Today|||52-Week Range

70.76

-14.90%

Year-to-Date

Latest ABBV News | Press Releases

Stock Market News for March 06, 2015 - Market News 10:55am / Zacks.com	Did AbbVie Just Grossly Overpay for Pharmacyclics Inc.? Mar 05 / MotleyFool.com
Jim Cramer on the Market: Here's the Return of Cult Stocks 9:33am / TheStreet.com	Credit Suisse: 8 Biotech and Health Care Stocks Add to Your Portfolio Right Now Mar 05 / TheStreet.com
AbbVie (ABBV) in Focus: Stock Falls by 5.7% - Tale of the Tape 9:29am / Zacks.com	Abbvie/Pharmacyclics: pay to play Mar 05 / FT.com
Benzinga's M&A Chatter for Thursday March 5, 2015 Mar 05 / Benzinga	Stock Futures Are Pointing Higher as ECB Lifts Growth Forecast Mar 05 / TheStreet.com
Jim Cramer's 'Mad Money' Recap: Why Aren't Well-Run Companies Getting Respect? Mar 05 / TheStreet.com	US Stock Futures Up Ahead Of Jobless Claims, Factory Orders Data Mar 05 / Benzinga
AbbVie (ABBV) Stock Declines In Trading Today Following $21B Pharmacyclics Purchase Mar 05 / TheStreet.com	AbbVie (ABBV) Is Today's Pre-Market Laggard Stock Mar 05 / TheStreet.com
Stocks Notch Small Gains Ahead of February Jobs Report Mar 05 / TheStreet.com	Why Pharmacyclics Inc. Stock Burst Higher Mar 05 / MotleyFool.com
The Under-the-Radar Reason Why Puma Biotechnology Inc. Rocketed 17% Higher Mar 05 / MotleyFool.com	March 5 Premarket Briefing: 10 Things You Should Know Mar 05 / TheStreet.com
AbbVie wins three-way fight over Pharmacyclics Mar 05 / FT.com	AbbVie Spending Historic Amount of Cash to Buy Half of a Cancer Drug Mar 05 / TheStreet.com
AbbVie joins the pharma chain reaction Mar 05 / FT.com	Q&A - why Abbvie had to strike $21bn Pharmacyclics deal Mar 05 / FT.com
Vertex climbs on drug approval hopes Mar 05 / FT.com	China Cuts Growth Target Mar 05 / TheStreet.com
Centerview builds record on pharma deals Mar 05 / FT.com	Stocks: 5 things to know before the open Mar 05 / CNNMoney.com
Stocks' Gains Are Limited in Lead-Up to February Jobs Report Mar 05 / TheStreet.com	AbbVie (ABBV) Is Today's Unusual Social Activity Stock Mar 04 / TheStreet.com
Benzinga's Volume Movers Mar 05 / Benzinga	AbbVie Inc (ABBV) Downgraded From Buy to Hold Mar 04 / TheStreet.com
Stocks Hitting 52-Week Highs Mar 05 / Benzinga	Analysts' Actions: AbbVie, Stratasys and More Mar 04 / TheStreet.com
Morning Market Losers Mar 05 / Benzinga	Dynavax Technologies: A New 'Best Idea' Mar 03 / TheStreet.com
Notable Mergers and Acquisitions 3/5: (ABBV)/(PCYC) (MNK) (SMTC) Mar 05 / Investing Channel	These Stocks Just Raised Their Dividends Mar 02 / MotleyFool.com
How These Healthcare Megadeals Helped Send the Market Higher Mar 05 / MotleyFool.com	Billionaire George Soros Just Dumped These 3 Dividend Stocks Mar 01 / MotleyFool.com
Stock Market News for March 05, 2015 - Market News Mar 05 / Zacks.com	Biotech Head-to-Head: Gilead vs. Celgene Feb 26 / MotleyFool.com
Morning Market Gainers Mar 05 / Benzinga	Express Scripts Earnings Set the Stage for Growth Feb 24 / MotleyFool.com
AbbVie to Acquire Pharmacyclics: What Wall Street's Saying Mar 05 / TheStreet.com	There Are Crazy Valuations, and Then There Are the Valuations of These 3 Stocks Feb 22 / MotleyFool.com
On the ECB & China's Growth - Ahead of Wall Street Mar 05 / Zacks.com	Pssst... Pfizer Just Told Investors That This is the Next Big Thing Feb 21 / MotleyFool.com
Benzinga's Top #PreMarket Losers Mar 05 / Benzinga	Will Express Scripts (ESRX) Beat Q4 Earnings Estimates? - Analyst Blog Feb 20 / Zacks.com
Stocks Grind Higher on ECB's QE While Costco Boosts S&P 500 Mar 05 / TheStreet.com	$20 Billion Market: Whatbs the Best Stock to Buy? Feb 20 / MotleyFool.com
Benzinga's Top #PreMarket Gainers Mar 05 / Benzinga	Monday interview: Flemming Ornskov, Shire CEO Feb 15 / FT.com

To view my watchlist

Not a member yet?

Millions of job openings!

See All Jobs ▶